Functioning in synergy with other cannabinoids, Delta-9 THC is the most widely known cannabinoid with numerous recognized therapeutic properties. It is primarily known for its psychoactive effects, but its potential benefits extend far beyond recreation. Studies have shown Delta-9 THC to be effective in managing pain, reducing nausea and vomiting, especially in chemotherapy patients, and stimulating appetite in individuals with eating disorders. Its broad range of therapeutic applications makes it a significant focus of ongoing research.

Recognized for its potential to alleviate anxiety and function as an anti-inflammatory agent, CBG (Cannabigerol) is being studied for its various therapeutic benefits. Researchers are exploring its role in reducing inflammation, managing pain, and potentially offering neuroprotective properties. This non-psychoactive cannabinoid is gaining attention for its unique pharmacological profile, which distinguishes it from other cannabinoids.

The most popular non-psychoactive cannabinoid, CBD is known for its calming properties among others. It has been extensively studied for its potential to reduce anxiety, alleviate pain, and serve as an anti-inflammatory agent. Additionally, CBD is being researched for its neuroprotective properties and potential benefits in treating conditions such as epilepsy and multiple sclerosis. Its versatility and safety profile make it a prominent subject in cannabinoid research.

Becoming recognized to aid in weight loss and regulate blood sugar levels, THCV (Tetrahydrocannabivarin) is being studied for its various therapeutic benefits. Researchers are exploring its role in reducing appetite, managing diabetes, and potentially offering neuroprotective properties. This cannabinoid, found in smaller quantities in cannabis, is gaining attention for its unique effects, which distinguish it from other cannabinoids.

Revered for its reputation to aid in sleep and act as a sedative, CBN (Cannabinol) is becoming well-known. Researchers are exploring its role in improving sleep quality, managing pain, and potentially offering antibacterial properties. This mildly psychoactive cannabinoid, which forms as THC ages, is gaining attention for its unique pharmacological profile and its potential use in sleep disorders.

Recognized for its potential to reduce inflammation and support brain health, CBC (Cannabichromene) is being studied for its various therapeutic benefits. Researchers are exploring its role in managing pain, promoting neurogenesis, and potentially offering antidepressant properties. This non-psychoactive cannabinoid is gaining attention for its synergistic effects with other cannabinoids and its unique contribution to the entourage effect in cannabis.